Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)

An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease

NCT03467958 ·Status: TERMINATED ·Phase: PHASE3

A Safety and Efficacy Study of Infliximab (Remicade) in Patients With Moderate to Severe Active Crohn's Disease

NCT00207662 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease (IM-UNITI)

NCT01369355 ·Status: COMPLETED ·Phase: PHASE3

Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab

NCT03107793 ·Status: COMPLETED ·Phase: PHASE3

Study for the Treatment of Crohn's Disease With Adacolumn

NCT00162942 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

NCT05995353 ·Status: RECRUITING ·Phase: PHASE3

Impact of Infliximab in Fistulizing Crohn's Disease on Health Care Resources (Study P04204)(TERMINATED)

NCT00705471 ·Status: TERMINATED

Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab

NCT00308581 ·Status: COMPLETED ·Phase: PHASE3

The Crohn's Therapy, Resource, Evaluation, and Assessment Tool Registry

NCT00553176 ·Status: COMPLETED

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

NCT03105102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

NCT04673357 ·Status: COMPLETED ·Phase: PHASE3

Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

NCT03440385 ·Status: COMPLETED ·Phase: PHASE3

CD INFORM: Investigating Natalizumab Through Further Observational Research and Monitoring

NCT00707512 ·Status: TERMINATED

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

NCT02403323 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

NCT02531113 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease

NCT00552344 ·Status: COMPLETED ·Phase: PHASE3

Post Marketing Surveillance of Remicade

NCT00724529 ·Status: COMPLETED

Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)

NCT00818272 ·Status: COMPLETED

A Phase II Study to Assess the Efficacy and Safety of Olokizumab in Patients With Crohn's Disease

NCT01635621 ·Status: WITHDRAWN ·Phase: PHASE2

MSC Intratissular Injection in Crohn Disease Patients

NCT03901235 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

NCT02326155 ·Status: TERMINATED

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

NCT00552058 ·Status: COMPLETED ·Phase: PHASE3

Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study

NCT02450513 ·Status: COMPLETED

A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease

NCT03782376 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)

NCT00796250 ·Status: TERMINATED ·Phase: PHASE3